- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Advanced systemic mastocytosis
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Midostaurin – March 2025
Midostaurin; Capsule 25 mg; Rydapt®
Last updated
12 March 2025